Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device
Clinical trial NCT01624662 · COMPLETED
Trial details
- NCT number
- NCT01624662
- Sponsor
- Optinose US Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-30
- Primary completion
- 2015-05-11
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.